×
Log in
Get Started
Travel
Technology
Sports
Marketing
Education
Career
Social Media
+ Explore all categories
Report -
Phase I Trial of an ICAM-1-Targeted Immunotherapeutic ...Clinical Trials: Immunotherapy Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Please pass captcha verification before submit form
